Skip to Main Content

Author Details

Louise C Strong
University of Texas MD Anderson Cancer Center
1972
188
65
PMIDPaper TitleJournal TitlePublished Year
30445420Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.Biostatistics2020
31719101Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.Cancer Res2020
31719099Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.Cancer Res2020
32156722Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition.Cancer Epidemiol Biomarkers Prev2020
32817165A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome.Genome Res2020
30445420Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.Biostatistics2020
31719101Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.Cancer Res2020
31719099Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.Cancer Res2020
32817165A pedigree-based prediction model identifies carriers of deleterious de novo mutations in families with Li-Fraumeni syndrome.Genome Res2020
32156722Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition.Cancer Epidemiol Biomarkers Prev2020
30573632Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.Blood2019
30573632Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.Blood2019
31517177Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.JCO Precis Oncol2019
31485091Bayesian Semiparametric Estimation of Cancer-specific Age-at-onset Penetrance with Application to Li-Fraumeni Syndrome.J Am Stat Assoc2019
30709875Hematologic malignancies and Li-Fraumeni syndrome.Cold Spring Harb Mol Case Stud2019
31517177Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutations.JCO Precis Oncol2019
31485091Bayesian Semiparametric Estimation of Cancer-specific Age-at-onset Penetrance with Application to Li-Fraumeni Syndrome.J Am Stat Assoc2019
30709875Hematologic malignancies and Li-Fraumeni syndrome.Cold Spring Harb Mol Case Stud2019
28988289Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.Fam Cancer2018
28988289Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.Fam Cancer2018
29105081Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.Cancer2018
29105081Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.Cancer2018
28818333Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.Trends Pharmacol Sci2017
31552380Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes.JCO Precis Oncol2017
28772291Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.JAMA Oncol2017
28818333Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.Trends Pharmacol Sci2017
28572266Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.Clin Cancer Res2017
28572263Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions.Clin Cancer Res2017
29059430Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.J Natl Cancer Inst2017
28301458The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.Genet Med2017
28254861Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical Practice.Cancer Res2017
28137790Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.Cancer Epidemiol Biomarkers Prev2017
31552380Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes.JCO Precis Oncol2017
28137790Estimating <i>TP53</i> Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.Cancer Epidemiol Biomarkers Prev2017
28254861Recommended Guidelines for Validation, Quality Control, and Reporting of <i>TP53</i> Variants in Clinical Practice.Cancer Res2017
28301458The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.Genet Med2017
29059430Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.J Natl Cancer Inst2017
28572266Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.Clin Cancer Res2017
28572263Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions.Clin Cancer Res2017
28772291Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.JAMA Oncol2017
26787237Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.Ann Oncol2016
27230363CANCER. The cancer predisposition revolution.Science2016
26787237Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol.Ann Oncol2016
26566882Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.J Med Genet2016
26700127Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.J Clin Oncol2016
26566882Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour.J Med Genet2016
27230363CANCER. The cancer predisposition revolution.Science2016
26700127Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study.J Clin Oncol2016
25764003Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.PLoS One2015
25764003Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays.PLoS One2015
  • 1 - 50 of 376

Recommended Authors

National Institutes of Health
Career Start Year 2007
Number of shared co-authors 17
University of Minnesota
Career Start Year 2004
Number of shared co-authors 5
Guy's and St Thomas' NHS Foundation Trust
Career Start Year 1998
Number of shared co-authors 19
College of Medicine, University of South Florida
Career Start Year 1995
Number of shared co-authors 19
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 9
Center for Applied Medical Research.
Career Start Year 1995
Number of shared co-authors 27
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 37
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 44
University of Washington
Career Start Year 1988
Number of shared co-authors 8
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1988
Number of shared co-authors 16
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 21
Vanderbilt University Medical Center
Career Start Year 1987
Number of shared co-authors 2
CancerLinQ LLC, American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 21
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 8
Sainte-Justine University Hospital Research Center
Career Start Year 1986
Number of shared co-authors 11
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 7
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 33
University of Utah
Career Start Year 1980
Number of shared co-authors 34
Pomeranian Medical University
Career Start Year 1979
Number of shared co-authors 36
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 33
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 13
University of Toronto
Career Start Year 1977
Number of shared co-authors 45
University of Adelaide
Career Start Year 1977
Number of shared co-authors 8
Instituto de Salud Carlos III
Career Start Year 1975
Number of shared co-authors 26
University of Washington
Career Start Year 1975
Number of shared co-authors 16
Institute for Cancer Research, Oslo University Hospital
Career Start Year 1972
Number of shared co-authors 34
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 25
Segal Cancer Centre, Jewish General Hospital
Career Start Year 1962
Number of shared co-authors 43
The Ohio State University Comprehensive Cancer Center
Career Start Year 1961
Number of shared co-authors 16
QIMR Berghofer Medical Research Institute
Career Start Year 1959
Number of shared co-authors 36

Collaborators

St. Jude Children's Research Hospital
Co-authored papers 18
Baylor College of Medicine
Co-authored papers 16
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Co-authored papers 11
Hospital for Sick Children
Co-authored papers 10
Dana-Farber Cancer Institute
Co-authored papers 9
Co-authored papers 9
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Clinical Genetics Branch, National Cancer Institute (NCI)
Co-authored papers 7
Co-authored papers 7
University of California irvine
Co-authored papers 7
Harvard Medical School
Co-authored papers 7
Department of Pediatrics University of Minnesota Minneapolis MN.
Co-authored papers 7
Rollins School of Public Health, Emory University
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania
Co-authored papers 5
St. Jude Children's Research Hospital
Co-authored papers 5
Flinders University Library, Flinders University
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
University of Oklahoma
Co-authored papers 5
and Blood Institute
Co-authored papers 5
Co-authored papers 4
Baylor College of Medicine
Co-authored papers 4
Garvan Institute of Medical Research
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 4
St. Jude Children's Research Hospital
Co-authored papers 4
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 4
University of Oxford
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Chicago
Co-authored papers 3
Co-authored papers 3